Two Seas Capital LP - Dec 31, 2024 SCHEDULE 13G Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

Filing Manager: Two Seas Capital LP
Reporting Manager: Two Seas Capital LP
Security: Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share
Symbol: ADAP
Shares outstanding: 1.53B shares
Disclosed Ownership: 89M shares
Ownership: 5.8%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 09:31 AM
Date of event: Dec 31, 2024
Next filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Two Seas Capital LP	5.8%	89M	89M	/s/ Sina Toussi	Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner
Two Seas Capital GP LLC	5.8%	89M	89M	/s/ Sina Toussi	Sina Toussi / Managing Member
Sina Toussi	5.8%	89M	89M	/s/ Sina Toussi	Sina Toussi / Self